BrainStorm
Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1
Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1
Will 2023 be a boom or bust year for new Alzheimer’s drugs?
In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School. Dr. Tanzi discusses the promising new drugs in a highly charged scientific environment and how these drugs have opened the door to advancement in the treatment of Alzheimer’s.
About This Episode
Will 2023 be a boom or bust year for new Alzheimer’s drugs?
In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School. Dr. Tanzi discusses the promising new drugs in a highly charged scientific environment and how these drugs have opened the door to advancement in the treatment of Alzheimer’s.